These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

155 related articles for article (PubMed ID: 36731101)

  • 1. Cannabis Use Disorder Treatment Preferences: A Pilot Survey in Current Users of Cannabis.
    Lile JA; Turner BW; Cox DH; Bonn-Miller MO; Katz NR; Shellenberg TP; Stoops WW; Strickland JC
    J Addict Med; 2023 Mar-Apr 01; 17(2):e87-e93. PubMed ID: 36731101
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Outcomes from a computer-assisted intervention simultaneously targeting cannabis and tobacco use.
    Lee DC; Budney AJ; Brunette MF; Hughes JR; Etter JF; Stanger C
    Drug Alcohol Depend; 2015 Oct; 155():134-40. PubMed ID: 26307942
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Treatment models for targeting tobacco use during treatment for cannabis use disorder: case series.
    Lee DC; Budney AJ; Brunette MF; Hughes JR; Etter JF; Stanger C
    Addict Behav; 2014 Aug; 39(8):1224-30. PubMed ID: 24813547
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Predictors of treatment utilization and barriers to treatment utilization among individuals with lifetime cannabis use disorder in the United States.
    Kerridge BT; Mauro PM; Chou SP; Saha TD; Pickering RP; Fan AZ; Grant BF; Hasin DS
    Drug Alcohol Depend; 2017 Dec; 181():223-228. PubMed ID: 29107786
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Reducing Cannabis Use in Young Adults With Psychosis Using iCanChange, a Mobile Health App: Protocol for a Pilot Randomized Controlled Trial (ReCAP-iCC).
    Tatar O; Abdel-Baki A; Wittevrongel A; Lecomte T; Copeland J; Lachance-Touchette P; Coronado-Montoya S; Côté J; Crockford D; Dubreucq S; L'Heureux S; Ouellet-Plamondon C; Roy MA; Tibbo PG; Villeneuve M; Jutras-Aswad D
    JMIR Res Protoc; 2022 Nov; 11(11):e40817. PubMed ID: 36427227
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Psychosocial and pharmacological treatments for cannabis use disorder and mental health comorbidities: a narrative review.
    Lees R; Hines LA; D'Souza DC; Stothart G; Di Forti M; Hoch E; Freeman TP
    Psychol Med; 2021 Feb; 51(3):353-364. PubMed ID: 33536109
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Systematic review of outcome domains and measures used in psychosocial and pharmacological treatment trials for cannabis use disorder.
    Lee DC; Schlienz NJ; Peters EN; Dworkin RH; Turk DC; Strain EC; Vandrey R
    Drug Alcohol Depend; 2019 Jan; 194():500-517. PubMed ID: 30530238
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Treatment of Adolescent Cannabis Use Disorders.
    Adams ZW; Marriott BR; Hulvershorn LA; Hinckley J
    Child Adolesc Psychiatr Clin N Am; 2023 Jan; 32(1):141-155. PubMed ID: 36410901
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Treatment of Adolescent Cannabis Use Disorders.
    Adams ZW; Marriott BR; Hulvershorn LA; Hinckley JD
    Psychiatr Clin North Am; 2023 Dec; 46(4):775-788. PubMed ID: 37879838
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Race, psychosocial characteristics, and treatment outcomes among individuals undergoing treatment for cannabis use disorder: A latent profile analysis based on preferred method of using cannabis.
    Ullrich HS; Torbati A; Fan W; Arbona C; Cano MA; Essa S; Harvey L; Vaughan EL; de Dios MA
    J Subst Abuse Treat; 2021 Dec; 131():108561. PubMed ID: 34275690
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Contingency management is associated with positive changes in attitudes and reductions in cannabis use even after discontinuation of incentives among non-treatment seeking youth.
    Cooke ME; Knoll SJ; Streck JM; Potter K; Lamberth E; Rychik N; Gilman JM; Evins AE; Schuster RM
    Drug Alcohol Depend; 2024 Mar; 256():111096. PubMed ID: 38277735
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Development of Mobile Contingency Management for Cannabis Use Reduction.
    Beckham JC; Calhoun PS; Chen Z; Dennis MF; Kirby AC; Treis ET; Hertzberg JS; Hair LP; Mann AJ; Budney AJ; Kimbrel NA
    Behav Ther; 2024 Jan; 55(1):1-13. PubMed ID: 38216224
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Cannabis use disorder treatment use and perceived treatment need in the United States: Time trends and age differences between 2002 and 2019.
    Askari MS; Keyes KM; Mauro PM
    Drug Alcohol Depend; 2021 Dec; 229(Pt A):109154. PubMed ID: 34741874
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Integrated cognitive-behavioral therapy for comorbid cannabis use and anxiety disorders: The impact of severity of cannabis use.
    Buckner JD; Morris PE; Zvolensky MJ
    Exp Clin Psychopharmacol; 2021 Jun; 29(3):272-278. PubMed ID: 34264732
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Comorbid Cannabis and Tobacco Use Disorders in Hospitalized Patients with Psychotic-Spectrum Disorders.
    Reeves LE; Gaudiano BA; Metrik J; Guzman Holst C; Morena A; Sydnor VJ; Weinstock LM; Epstein-Lubow G
    J Dual Diagn; 2018; 14(3):171-180. PubMed ID: 30265850
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Cannabis use and cannabis use disorder.
    Connor JP; Stjepanović D; Le Foll B; Hoch E; Budney AJ; Hall WD
    Nat Rev Dis Primers; 2021 Feb; 7(1):16. PubMed ID: 33627670
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Depressive symptoms and cannabis use in a placebo-controlled trial of N-Acetylcysteine for adult cannabis use disorder.
    Tomko RL; Baker NL; Hood CO; Gilmore AK; McClure EA; Squeglia LM; McRae-Clark AL; Sonne SC; Gray KM
    Psychopharmacology (Berl); 2020 Feb; 237(2):479-490. PubMed ID: 31712969
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Anxiety sensitivity and cigarette use on cannabis use problems, perceived barriers for cannabis cessation, and self-efficacy for quitting among adults with cannabis use disorder.
    Orr MF; Heggeness LF; Mehta N; Moya J; Manning K; Garey L; Hogan J; de Dios M; Zvolensky MJ
    Addict Behav; 2023 Feb; 137():107509. PubMed ID: 36194977
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Psychosocial functioning among regular cannabis users with and without cannabis use disorder.
    Foster KT; Arterberry BJ; Iacono WG; McGue M; Hicks BM
    Psychol Med; 2018 Aug; 48(11):1853-1861. PubMed ID: 29173210
    [TBL] [Abstract][Full Text] [Related]  

  • 20. [Cannabis cessation interventions offered to young French users: predictors of follow-up].
    Abdoul H; Le Faou AL; Bouchez J; Touzeau D; Lagrue G
    Encephale; 2012 Apr; 38(2):141-8. PubMed ID: 22516272
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 8.